| Literature DB >> 34197737 |
Shashank Hambarde1, Chi-Lin Tsai2, Raj K Pandita3, Albino Bacolla2, Anirban Maitra4, Vijay Charaka5, Clayton R Hunt5, Rakesh Kumar6, Oliver Limbo7, Remy Le Meur8, Walter J Chazin8, Susan E Tsutakawa9, Paul Russell7, Katharina Schlacher10, Tej K Pandita11, John A Tainer12.
Abstract
Stalled DNA replication fork restart after stress as orchestrated by ATR kinase, BLM helicase, and structure-specific nucleases enables replication, cell survival, and genome stability. Here we unveil human exonuclease V (EXO5) as an ATR-regulated DNA structure-specific nuclease and BLM partner for replication fork restart. We find that elevated EXO5 in tumors correlates with increased mutation loads and poor patient survival, suggesting that EXO5 upregulation has oncogenic potential. Structural, mechanistic, and mutational analyses of EXO5 and EXO5-DNA complexes reveal a single-stranded DNA binding channel with an adjacent ATR phosphorylation motif (T88Q89) that regulates EXO5 nuclease activity and BLM binding identified by mass spectrometric analysis. EXO5 phospho-mimetic mutant rescues the restart defect from EXO5 depletion that decreases fork progression, DNA damage repair, and cell survival. EXO5 depletion furthermore rescues survival of FANCA-deficient cells and indicates EXO5 functions epistatically with SMARCAL1 and BLM. Thus, an EXO5 axis connects ATR and BLM in directing replication fork restart.Entities:
Keywords: ATR phosphorylation; Bloom; Fanconi anemia; SCE; exonuclease; fork restart; genetic instability; interstrand crosslink repair; replication stress; sister chromatid exchange; tumor proliferation
Mesh:
Substances:
Year: 2021 PMID: 34197737 PMCID: PMC8720176 DOI: 10.1016/j.molcel.2021.05.027
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 19.328